Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans

Paul Tuijnenburg(Amsterdam UMC Location University of Amsterdam), Hana Lango Allen(NHS Blood and Transplant), Siobhan O. Burns(Royal Free London NHS Foundation Trust), Daniel Greene(NHS Blood and Transplant), Machiel H. Jansen(Amsterdam UMC Location University of Amsterdam), Emily Staples(University of Cambridge), Jonathan Stephens(NHS Blood and Transplant), Keren Carss(NHS Blood and Transplant), Daniele Biasci(University of Cambridge), Helen Baxendale(University of Cambridge), Moira Thomas(Queen Elizabeth University Hospital), Anita Chandra(University of Cambridge), Sorena Kiani‐Alikhan(Royal Surrey County Hospital), Hilary Longhurst(Barts Health NHS Trust), Suranjith L. Seneviratne(Royal Free London NHS Foundation Trust), Eric Oksenhendler(Assistance Publique – Hôpitaux de Paris), Ilenia Simeoni(University of Cambridge), Godelieve J. de Bree(Amsterdam UMC Location University of Amsterdam), Anton T. J. Tool(Sanquin), Ester M. M. van Leeuwen(Amsterdam UMC Location University of Amsterdam), Eduard H.T.M. Ebberink(Sanquin), Alexander B. Meijer(Sanquin), Salih Tuna(NHS Blood and Transplant), Deborah Whitehorn(NHS Blood and Transplant), Matthew A. Brown(NHS Blood and Transplant), Ernest Turro(NHS Blood and Transplant), Adrian J. Thrasher(Great Ormond Street Hospital), Kenneth G. C. Smith(University of Cambridge), James Thaventhiran(University of Cambridge), Taco W. Kuijpers(Amsterdam UMC Location University of Amsterdam), Zoe Adhya, Hana Alachkar(NHS Blood and Transplant), Ariharan Anantharachagan, Richard Antrobus, Gururaj Arumugakani, Chiara Bacchelli, Helen Baxendale(University of Cambridge), Claire Bethune, Shahnaz Bibi, Barbara Boardman, Claire Booth, Michael J. Browning, Mary Brownlie, Siobhan O. Burns(Royal Free London NHS Foundation Trust), Anita Chandra(University of Cambridge), Hayley Clifford, Nichola Cooper, Sophie Davies, John Dempster, Lisa Devlin, Rainer Döffinger, Elizabeth Drewe, David Edgar, William Egner, Tariq El‐Shanawany, Bobby Gaspar, Rohit Ghurye, Kimberley Gilmour, Sarah Goddard, Pavel Gordins, Sofia Grigoriadou, Scott Hackett, Rosie Hague, Lorraine Harper, Grant Hayman, Archana Herwadkar, Stephen Hughes(NHS Blood and Transplant), Aarnoud Huissoon, Stephen Jolles(NHS Blood and Transplant), Julie R. Jones, Peter Kelleher, Nigel Klein, Taco W. Kuijpers(Amsterdam UMC Location University of Amsterdam), Dinakantha Kumararatne, James Laffan(University of Cambridge), Hana Lango Allen(NHS Blood and Transplant), Sara Lear, Hilary Longhurst(Barts Health NHS Trust), Lorena Lorenzo, Jesmeen Maimaris, Ania Manson(Royal Surrey County Hospital), Elizabeth McDermott, Hazel Millar, Anoop Mistry, Valerie Morrisson, Sai Murng, Iman Nasir, Sergey Nejentsev, Sadia Noorani, Éric Oksenhendler(Assistance Publique – Hôpitaux de Paris), Mark Ponsford, Waseem Qasim, Ellie Quinn, Isabella Quinti, Alex Richter(Sanquin), Crina Samarghitean, Ravishankar Sargur, Sinisa Savic, Suranjith L. Seneviratne(Royal Free London NHS Foundation Trust), Carrock Sewall, Fiona Shackley, Ilenia Simeoni(University of Cambridge), Kenneth G. C. Smith(University of Cambridge), Emily Staples(University of Cambridge), Hans J. Stauss(NHS Blood and Transplant), Cathal Steele, James Thaventhiran(University of Cambridge), Moira Thomas(Queen Elizabeth University Hospital), Adrian J. Thrasher(Great Ormond Street Hospital), Steve Welch, Lisa Willcocks, Sarita Workman, Austen Worth, Nigel Yeatman, Patrick Yong, Sofie Ashford, John R. Bradley, Debra Fletcher, Tracey Hammerton, Roger James(University of Cambridge), Nathalie Kingston, Willem H. Ouwehand, Christopher J. Penkett, F. Lucy Raymond, Kathleen Stirrups(Netherlands Institute for Neuroscience), Marijke Veltman, Timothy M. Young, Sofie Ashford, Matthew A. Brown(NHS Blood and Transplant), Emma Clement, John Davis, Eleanor Dewhurst, Marie Erwood, Amy Frary, Rachel Linger, Jennifer M. Martin, Sofia Papadia, Karola Rehnström, William J. Astle, Antony Attwood, Marta Bleda, Keren Carss(NHS Blood and Transplant), Louise C. Daugherty, Sri V. V. Deevi, Stefan Gräf, Daniel Greene(NHS Blood and Transplant), Csaba Halmagyi, Matthias Haimel, Fengyuan Hu(Barts Health NHS Trust), Roger James(University of Cambridge), Hana Lango Allen(NHS Blood and Transplant), Vera Matser, Stuart Meacham, Karyn Mégy, Christopher J. Penkett, Olga Shamardina, Kathleen Stirrups(Netherlands Institute for Neuroscience), Catherine Titterton, Salih Tuna(NHS Blood and Transplant), Ernest Turro(NHS Blood and Transplant), Ping Yu, Julie von Ziegenweldt, Abigail Furnell(Netherlands Institute for Neuroscience), Rutendo Mapeta(Netherlands Institute for Neuroscience), Ilenia Simeoni(University of Cambridge), Simon Staines(Netherlands Institute for Neuroscience), Jonathan Stephens(NHS Blood and Transplant), Kathleen Stirrups(Netherlands Institute for Neuroscience), Deborah Whitehorn(NHS Blood and Transplant), Paula Rayner-Matthews(Netherlands Institute for Neuroscience), Christopher D. Watt
Journal of Allergy and Clinical Immunology
March 2, 2018
Cited by 233Open Access
Full Text

Abstract

BACKGROUND: The genetic cause of primary immunodeficiency disease (PID) carries prognostic information. OBJECTIVE: We conducted a whole-genome sequencing study assessing a large proportion of the NIHR BioResource-Rare Diseases cohort. METHODS: In the predominantly European study population of principally sporadic unrelated PID cases (n = 846), a novel Bayesian method identified nuclear factor κB subunit 1 (NFKB1) as one of the genes most strongly associated with PID, and the association was explained by 16 novel heterozygous truncating, missense, and gene deletion variants. This accounted for 4% of common variable immunodeficiency (CVID) cases (n = 390) in the cohort. Amino acid substitutions predicted to be pathogenic were assessed by means of analysis of structural protein data. Immunophenotyping, immunoblotting, and ex vivo stimulation of lymphocytes determined the functional effects of these variants. Detailed clinical and pedigree information was collected for genotype-phenotype cosegregation analyses. RESULTS: B-cell population. Combined with identification of the disease-causing variant, this distinguishes between healthy subjects, asymptomatic carriers, and clinically affected cases. CONCLUSION: We show that heterozygous loss-of-function variants in NFKB1 are the most common known monogenic cause of CVID, which results in a temporally progressive defect in the formation of immunoglobulin-producing B cells.


Related Papers

No related papers found

Powered by citation graph analysis